Skip to main content
SpringerLink
Log in

Promoter methylation reduces C/EBPδ (CEBPD) gene expression in the SUM-52PE human breast cancer cell line and in primary breast tumors

Breast Cancer Research and Treatment Aims and scope Submit manuscript

Cite this article

Summary

CCAAT/Enhancer Binding Proteins (C/EBPs) are a highly conserved family of leucine zipper proteins that regulate cell growth and differentiation. C/EBPδ functions in the initiation and maintenance of mammary epithelial cell G0 growth arrest and ‘loss of function’ alterations in C/EBPδ gene expression have been reported in human breast cancer and in rodent carcinogen-induced mammary tumors. The molecular mechanism underlying reduced C/EBPδ gene expression in mammary tumorigenesis, however, is unknown. In this report we demonstrate that C/EBPδ gene expression is undetectable in the SUM-52PE human breast cancer cell line and that silencing of SUM-52PE C/EBPδ gene expression is due to epigenetic promoter hypermethylation (26/27 CpGs methylated). The hypermethylated SUM-52PE C/EBPδ gene promoter is associated with reduced levels of acetylated Histone H4, consistent with a closed, transcriptionally inactive chromatin conformation. Treatment with 5′-aza-cytidine and trichostatin A (TSA) re-activates cytokine-induced SUM-52PE C/EBPδ gene expression. C/EBPδ gene expression is reduced to virtually undetectable levels in 32% (18/57) of primary human breast tumors. Site-specific CpG methylation was observed in 33% (6/18) of the low C/EBPδ expressing primary breast tumors. CpG methylation adjacent to the C/EBPδ proximal promoter Sp1 site was associated with reduced C/EBPδ expression in a primary breast cancer sample. Electromobility shift assays (EMSA) demonstrated a significant reduction in binding to oligos containing the CpG methylation 5′ to the Sp1 binding site. These results demonstrate a direct link between C/EBPδ gene promoter hyper- and site specific-methylation and reduced C/EBPδ gene expression in breast cancer cell lines and primary breast tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

C/EBP:

CCAAT/Enhancer Binding Protein

DMBA:

7,12-dimethylbenz[a]anthracene

JAK1, JAK2, TYK2:

Janus Kinases

MSPCR:

Methylation specific PCR

PhIP:

2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine

STAT3:

signal transducer and activator of transcription3

References

  1. Ramji DP, Foka P, 2002. CCAAT/enhancer-binding proteins: structure, function and regulation Biochem J 365:561–575

    PubMed  CAS  Google Scholar 

  2. Vinson C, Myakishev M, Acharya A, Mir A, Moll J, Bonowich M, 2002. Classification of human B-ZIP proteins based on dimerization properties Mol Cell Biol 22:6321–6335

    Article  PubMed  CAS  Google Scholar 

  3. Timchenko NA, Wilde M, Darlington GJ, 1999. C/EBPα regulates formation of S-Phase-Specific E2F-p107 complexes in livers of newborn mice Mol Cell Biol 19:2936–2945

    PubMed  CAS  Google Scholar 

  4. Harris TE, Albrecht JH, Nakanishi M, Darlington GJ, 2001. CCAAT/Enhancer-binding Protein-α Cooperates with p21 to Inhibit Cyclin-dependent Kinase-2 Activity and Induces Growth Arrest Independent of DNA Binding J Biol Chem 276:29200–29209

    Article  PubMed  CAS  Google Scholar 

  5. Wang H, Iakova P, Wilde M, Welm A, Goode T, Roesler WJ, Timchenko NA, 2001. C/EBPalpha arrests cell proliferation through direct inhibition of Cdk2 and Cdk4 Mol Cell 8:817–828

    Article  PubMed  CAS  Google Scholar 

  6. Slomiany BA, D’Arigo KL, Kelly MM, Kurtz DT, 2000. C/EBPα inhibits cell growth via direct repression of E2F-DP-mediated transcription Mol Cell Biol 20:5986–5997

    Article  PubMed  CAS  Google Scholar 

  7. Wang H, Goode T, Iokova P, Albrecht JH, Timchenko NA, 2002. C/EBPα triggers proteasome-dependent degradation of cdk4 during growth arrest EMBO J 21:930–941

    Article  PubMed  CAS  Google Scholar 

  8. Chien P-L, Riley DJ, Chen-Kiang S, Lee W-H, 1996. Retinoblastoma protein directly interacts with and activates the transcription factor NF-IL6 Proc Nat Acad Sci 93:465–469

    Article  PubMed  Google Scholar 

  9. D’Alo F, Johansen LM, Nelson EA, Radomska HS, Evans EK, Zhang P, Nerlov C, Tenen DG, 2003. The amino terminal and E2F interaction domains are critical for C/EBPα-mediated induction of granulopoietic development of hematopoietic cells Blood 102: 3163–3171

    Article  PubMed  CAS  Google Scholar 

  10. Gery S, Gombart AF, Fung YK, Koeffler HP, 2004. C/EBPɛ interacts with retinoblastoma and E2F1 during granulopoiesis Blood 103:828–835

    Article  PubMed  CAS  Google Scholar 

  11. Ron D, 1997. TLS-CHOP and the role of RNA-binding proteins in oncogenic transformation. In, Rauscher FJ III, Vogt PK, (eds) Chromosomal Translocations and Oncogenic Transcription factors. Springer-Verlag, Heidelberg, Germany, 131–142

    Google Scholar 

  12. DG Tenen, 2001. Abnormalities of the CEBP alpha transcription factor: a major target in acute myeloid leukemia Leukemia 15:688–689

    Article  PubMed  CAS  Google Scholar 

  13. Halmos B, Huettner CS, Kocher O, Ferenczi K, Karp DD, Tenen DG, 2002. Down-regulation and antiproliferative role of C/EBPα in lung cancer Cancer Res 62:528–534

    PubMed  CAS  Google Scholar 

  14. Zahnow CA, 2002. CCAAT/Enhancer binding protein in normal mammary development and breast cancer Breast Cancer Res 4:113–121

    Article  PubMed  CAS  Google Scholar 

  15. Porter D, Krop IE, Nasser S, Sgroi D, Kaelin C, Marks JR, Riggins G, Polyak KA, 2001. SAGE (Serial Analysis of Gene Expression) view of breast tumor progression Cancer Res 61:5697–5702

    PubMed  CAS  Google Scholar 

  16. Porter D, Lahti-Domenici J, Keshaviah A, Bae YK, Argani P, Marks J, Richardson A, Cooper A, Strausberg R, Riggins GJ, Schnitt S, Gabrielson E, Gelman R,Polyak K, 2003. Molecular markers in ductal carcinoma in situ of the breast Mol Cancer Res 1:362–375

    PubMed  CAS  Google Scholar 

  17. Kuramoto T, Morimura K, Yamashita S, Okochi E, Watanabe N, Ohta T, Ohki M, Fukushima S, Sugimura T, Ushijima T, 2002. Etiology-specific gene expression profiles in rat mammary carcinomas Cancer Res 62:3592–3597

    PubMed  CAS  Google Scholar 

  18. O’Rourke JP, Yuan R, DeWille JW, 1997. CCAAT/Enhancer binding protein-delta is induced in growth arrested mouse mammary epithelial cells J Biol Chem 272:6291–6296

    Article  PubMed  CAS  Google Scholar 

  19. O’Rourke JP, Newbound GC, Hutt JA, DeWille JW, 1999. C/EBPδ regulates mammary epithelial cell G0 growth arrest and apoptosis J Biol Chem 274:16582–16589

    Article  PubMed  CAS  Google Scholar 

  20. O’Rourke JP, Hutt JA, DeWille JW, 1999. Transcriptional regulation of the C/EBPδ in G0 growth arrested mouse mammary epithelial cells Biochem Biophys Res Comm 262: 696–701

    Article  PubMed  CAS  Google Scholar 

  21. Hutt JA, O’Rourke JP, DeWille JW, 2000. Stat3 activates C/EBPδ gene transcription in G0 growth arrested mouse mammary epithelial cells, in involuting mouse mammary gland J Biol Chem 275:29123–29131

    Article  PubMed  CAS  Google Scholar 

  22. Hutt JA, DeWille JW, 2002. Oncostatin M Induces growth arrest of mammary epithelial cells via a CCAAT/Enhancer binding protein delta dependent pathway Mol Cancer Ther 1:601–610

    PubMed  CAS  Google Scholar 

  23. Sivko GS, DeWille JW, 2004. CCAAT/enhancer binding protein delta (C/EBPdelta) regulation and expression in human mammary epithelial cells: I. “Loss of function” alterations in the C/EBPdelta growth inhibitory pathway in breast cancer cell lines J Cell Biochem 93:830–843

    Article  PubMed  CAS  Google Scholar 

  24. Sivko GS, Sanford DC, Dearth LD, Tang D, DeWille JW, 2004. CCAAT/enhancer binding protein delta (C/EBPdelta) regulation and expression in human mammary epithelial cells: II. Analysis of activating signal transduction pathways, transcriptional, post-transcriptional, and post-translational control J Cell Biochem 93:844–856

    Article  PubMed  CAS  Google Scholar 

  25. Gigliotti AP, Johnson PJ, Sterneck E, DeWille JW, 2003. CCAAT/Enhancer Binding proteinδ (C/EBPδ) knockout mice exhibit increased mammary epithelial cell proliferation Exp Biol Med 228:278–285

    CAS  Google Scholar 

  26. Vegesan V, Takeuchi S, Hofmann W-K, Ikeezoe T, Tavor S, Krug U, Fermin AC, Heaney A, Miller CW, Koeffler HP, 2001. C/EBP-β, C/EBP-δ, PU.1, AML1 genes: mutational analysis in 381 samples of hematopietic and solid malignancies Leukemia Res 26:451–457

    Article  Google Scholar 

  27. Tang D, DeWille JW, 2003. Detection of polymorphisms in the human C/EBPδ gene by single strand conformation polymorphism (SSCP) analysis Mol Cellular Probes 17:11–14

    Article  CAS  Google Scholar 

  28. Nephew KP, TH-M Huang, 2003. Epigenetic gene silencing in cancer initiation and progression Cancer Letts 190:125–133

    Article  CAS  Google Scholar 

  29. Widschwendter M, Jones PA, 2002. DNA methylation and breast carcinogenesis Oncogene 21:5462–5482

    Article  PubMed  CAS  Google Scholar 

  30. Zhu W-G, Srinivasan K, Dai Z, Duan W, Druhan LJ, Ding H, Yee L, Villalona-Calero A, Plass C, Otterson GA, 2003. Methylation of adjacent CpG sites affects Sp1/Sp3 binding and activity in the p21 cip1 promoter Mol Cell Biol 23:4056–4065

    Article  PubMed  CAS  Google Scholar 

  31. Ethier SP, Kokeny EK, Ridings JW, Dilts A, 1996. erbB family receptor expression and growth regulation in a newly isolated human breast cancer cell line Cancer Res 56:899–907

    PubMed  CAS  Google Scholar 

  32. Cantwell CA, Sterneck E, Johnson PF, 1998. Interleukin-6-specific activation of the C/EBPdelta gene in hepatocytes is mediated by Stat3 and Sp1 Mol Cell Biol 18:2108–2117

    PubMed  CAS  Google Scholar 

  33. Sanford DC, DeWille JW, 2005. C/EBPδ is a downstream mediator of IL-6 induced growth inhibition of prostate cancer cells The Prostate 63:143–154

    Article  PubMed  CAS  Google Scholar 

  34. Irvine RA, Lin IG, Hsieh C-L, 2002. DNA methylation has a local effect on transcription and histone acetylation Mol Cell Biol 22:6689–6696

    Article  PubMed  CAS  Google Scholar 

  35. Klochendler-Yeivin A, Yaniv M, 2001. Chromatin modifiers and tumor suppression Biochim et Biophys Acta 1551:M1–M10

    CAS  Google Scholar 

  36. Peterson CL, Laniel MA, 2004. Histones and histone modifications Current Biol 14:R546–551

    Article  CAS  Google Scholar 

  37. Sherr CJ, 2004. Principles of tumor suppression Cell 116:235–246

    Article  PubMed  CAS  Google Scholar 

  38. Wood S, Schertzer M, Yaremko ML, 1995. Sequence identity locates CEBPD and FGFR1 to mapped human loci within proximal 8p Cytogenet Cell Genet 70 (3–4): 188–191

    Article  PubMed  CAS  Google Scholar 

  39. Nagaoka M, Shiraishi Y, Sugiura Y, 2001. Selected base sequence outside the target binding site of zinc finger protein Sp1 Nucl Acid Res 29:4920–4929

    Article  CAS  Google Scholar 

  40. Arapshian A, Kuppumbatti YS, Mira-y-Lopez R, 2000. Methylation of conserved CpG sites neighboring the beta retinoic acid response element may mediate retinoic acid receptor beta gene silencing in MCF-7 breast cancer cells Oncogene 19:4066–4070

    Article  PubMed  CAS  Google Scholar 

  41. Mancini DN, Rodenhiser DI, Ainsworth PJ, O’Malley FP, Singh SM, Xing W, Archer T, 1998. CpG methylation within the 5′ regulatory region of the BRCA1 gene is tumor specific and includes a putative CREB binding site Oncogene 16:1161–1169

    Article  PubMed  CAS  Google Scholar 

  42. Mancini-DiNardo DN, Butcher DT, Robinson DP, Archer TK, Rodenhiser DI, 2001. Functional analysis of CpG methylation in the BRCA1 promoter region Oncogene 20:5331–5340

    Article  PubMed  CAS  Google Scholar 

  43. Kerangueven F, Noguchi T, Coulier F, Allione F, Wargniez V, Simony-Lafontaine J, Longy M, Jacquemier J, Sobol H, Eisinger F, Birnbaum D, 1997. Genome-wide search for loss of heterozygosity shows extensive genetic diversity of human breast carcinomas Cancer Res 57:5469–5474

    PubMed  CAS  Google Scholar 

  44. Smiraglia DJ, Rush LJ, Fruhwald MC, Dai Z, Held WA, Costello JF, Lang JC, Eng C, Li B, Wright FA, Caligiuri MA, Plass C, 2001. Excessive CpG island hypermethylation in cancer cell lines versus primary malignancies Hum Mol Genet 10:1413–1419

    Article  PubMed  CAS  Google Scholar 

  45. Ueki T, Walter KM, Skinner H, Jaffee E, Hruban R, Goggins M, 2002. Aberrant CpG island methylation in cancer cell lines arises in the primary cancer from which they were derived Oncogene 21: 2114–2117

    Article  PubMed  CAS  Google Scholar 

  46. Paz MF, Fraga MF, Avila S, Guo M, Pollan M, Herman JG, Estellar MA, 2003. Systematic profile of DNA methylation in human cancer cell lines Cancer Res 63:1114–1121

    PubMed  CAS  Google Scholar 

  47. Scherf U, Ross DT, Waltham M, Smith LH, Lee JK, Tanabe L, Kohn KW, Reinhold WC, Myers TG, Andrews DT, Scudiero DA, Eisen MB, Sausville EA, Pommier Y, Botsein D, Brown PO, Weinstein JN, 2000. A gene expression database for the molecular pharmacology of cancer Nature Genet 24:236–244

    Article  PubMed  CAS  Google Scholar 

  48. Grant SL, Begley CG, 1999 The Oncostatin M signaling pathway. reversing the neoplastic phenotype Mol Med Today 5:406–412

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Veterinary Biosciences and Ohio State Comprehensive Cancer Center, Ohio State University, Columbus, Ohio, USA

    D. Tang, G.S. Sivko & J.W. DeWille

  2. Department of Veterinary Biosciences, Ohio State University, 1925 Coffey Road, Columbus, Ohio, 43210, USA

    J.W. DeWille

Authors
  1. D. Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G.S. Sivko
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J.W. DeWille
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J.W. DeWille.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Tang, D., Sivko, G. & DeWille, J. Promoter methylation reduces C/EBPδ (CEBPD) gene expression in the SUM-52PE human breast cancer cell line and in primary breast tumors. Breast Cancer Res Treat 95, 161–170 (2006). https://doi.org/10.1007/s10549-005-9061-3

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-005-9061-3

Key Words:

search

Navigation